TY - JOUR
T1 - The effect of anti-mu suppression of γM and γG on the production of γE*
AU - Dwyer, J. M.
AU - Rosenbaum, J. T.
AU - Lewis, S.
PY - 1976/4/1
Y1 - 1976/4/1
N2 - Newborn mice were treated from the day of birth with either bovine gamma globulin or anti-mu chain sera. The latter was administered using a protocol known to produce suppression of γM, γG, and γA production. Subsequent immunization with ovalbumin (OA) in alum was attempted to see if suppression of γM, γG, and γA classes of antibody would also be accompanied by suppression of γE-producing capacity. γG and γM antibody to OA and mercaptoethanol-resistant (γG) antibody to OA were measured by passive hemagglutination; γG and γE anti-OA antibodies were measured by passive cutaneous anaphylaxis. Anti-mu suppression was achieved with significant reduction in γM and γG antibodies. γE antibodies were not affected, suggesting an ontogenetic development for γE-bearing lymphocytes independent of the previously described γM to γG to γA ontogenetic sequence.
AB - Newborn mice were treated from the day of birth with either bovine gamma globulin or anti-mu chain sera. The latter was administered using a protocol known to produce suppression of γM, γG, and γA production. Subsequent immunization with ovalbumin (OA) in alum was attempted to see if suppression of γM, γG, and γA classes of antibody would also be accompanied by suppression of γE-producing capacity. γG and γM antibody to OA and mercaptoethanol-resistant (γG) antibody to OA were measured by passive hemagglutination; γG and γE anti-OA antibodies were measured by passive cutaneous anaphylaxis. Anti-mu suppression was achieved with significant reduction in γM and γG antibodies. γE antibodies were not affected, suggesting an ontogenetic development for γE-bearing lymphocytes independent of the previously described γM to γG to γA ontogenetic sequence.
UR - http://www.scopus.com/inward/record.url?scp=0017254932&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0017254932&partnerID=8YFLogxK
U2 - 10.1084/jem.143.4.781
DO - 10.1084/jem.143.4.781
M3 - Article
C2 - 1082916
AN - SCOPUS:0017254932
SN - 0022-1007
VL - 143
SP - 781
EP - 790
JO - Journal of Experimental Medicine
JF - Journal of Experimental Medicine
IS - 4
ER -